Publication | Closed Access

Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells

Breast OncologySignaling PathwayPma-induced Mmp-9 ExpressionBreast CancerTumor SuppressorRadiation OncologyMedicineCell BiologyCell SignalingAp-1 ActivationTumor BiologyEndocrine-related Cancer